The present study provides a retrospective analysis of a homogenous cohort of IDH-wildtype glioblastoma patients who were in good clinical condition at the time of diagnosis and were treated homogeneously according to the EORTC protocol. This evidence concerns the gene IDH1 and glioblastoma.